A

Adocia SA
PAR:ADOC

Watchlist Manager
Adocia SA
PAR:ADOC
Watchlist
Price: 8.63 EUR -11.4%
Market Cap: 157.8m EUR

EV/EBITDA
Enterprise Value to EBITDA

-22.7
Current
-13.4
Median
5.5
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-22.7
=
Enterprise Value
153.5m EUR
/
EBITDA
-6.8m EUR
EBITDA Growth EV/EBITDA to Growth
FR
A
Adocia SA
PAR:ADOC
Average EV/EBITDA: 15.8
Negative Multiple: -22.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 782 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.9
10%
1.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
6%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.1 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.7
17%
1.2
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
9%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -470.4 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.8 N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
2.8
2-Years Forward
EV/EBITDA
3.3
3-Years Forward
EV/EBITDA
N/A